Zhongchao Inc (ZCMD) ニュース

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Zhongchao Inc. Announces 1-for-10 Share Consolidation

Zhongchao Inc. Announces 1-for-10 Share Consolidation PR Newswire SHANGHAI, Feb. 27, 2024 SHANGHAI, Feb. 27, 2024 /PRNewswire/ -- Zhongchao Inc...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments PR Newswire SHANGHAI, Dec. 11...

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day PR...

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients PR Newswire SHANGHAI, Sept. 25, 2023 SHANGHAI, Sept. 25...

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management PR Newswire SHANGHAI, Aug. 24, 2023...